RT Journal Article
SR Electronic
T1 Prognostic Relevance of Celiac Lymph Node Involvement in Ovarian Cancer
JF International Journal of Gynecologic Cancer
JO Int J Gynecol Cancer
FD BMJ Publishing Group Ltd
SP 48
OP 53
DO 10.1097/IGC.0000000000000041
VO 24
IS 1
A1 Alejandra Martínez
A1 Cristophe Pomel
A1 Thomas Filleron
A1 Marjolein De Cuypere
A1 Eliane Mery
A1 Denis Querleu
A1 Laurance Gladieff
A1 Mathieu Poilblanc
A1 Gwénaël Ferron
YR 2014
UL http://ijgc.bmj.com/content/24/1/48.abstract
AB Objective The aim of the study was to report on the oncologic outcome of the disease spread to celiac lymph nodes (CLNs) in advanced-stage ovarian cancer patients.Methods All patients who had CLN resection as part of their cytoreductive surgery for epithelial ovarian, fallopian, or primary peritoneal cancer were identified. Patient demographic data with particular emphasis on operative records to detail the extent and distribution of the disease spread, lymphadenectomy procedures, pathologic data, and follow-up data were included.Results The median follow-up was 26.3 months. The median overall survival values in the group with positive CLNs and in the group with negative CLNs were 26.9 months and 40.04 months, respectively. The median progression-free survival values in the group with metastatic CLNs and in the group with negative CLNs were 8.8 months and 20.24 months, respectively (P = 0.053). Positive CLNs were associated with progression during or within 6 months after the completion of chemotherapy (P = 0.0044). Tumor burden and extensive disease distribution were significantly associated with poor progression-free survival, short-term progression, and overall survival. In multivariate analysis, only the CLN status was independently associated with short-term progression.Conclusions Disease in the CLN is a marker of disease severity, which is associated to a high-risk group of patients with presumed adverse tumor biology, increased risk of lymph node progression, and worst oncologic outcome.